Author
Listed:
- Valentina Cipriani
(Queen Mary University of London
University College London
Moorfields Eye Hospital NHS Foundation Trust
University College London)
- Laura Lorés-Motta
(Radboud University Medical Center)
- Fan He
(University of Manchester)
- Dina Fathalla
(Cardiff University)
- Viranga Tilakaratna
(University of Manchester)
- Selina McHarg
(University of Manchester)
- Nadhim Bayatti
(University of Manchester)
- İlhan E. Acar
(Radboud University Medical Center)
- Carel B. Hoyng
(Radboud University Medical Center)
- Sascha Fauser
(University Hospital of Cologne
Roche Pharma Research and Early Development)
- Anthony T. Moore
(University College London
Moorfields Eye Hospital NHS Foundation Trust
University of California San Francisco)
- John R. W. Yates
(University College London
Moorfields Eye Hospital NHS Foundation Trust
University of Cambridge)
- Eiko K. de Jong
(Radboud University Medical Center)
- B. Paul Morgan
(Cardiff University)
- Anneke I. den Hollander
(Radboud University Medical Center
Radboud University Medical Centre)
- Paul N. Bishop
(University of Manchester
Manchester Academic Health Science Centre)
- Simon J. Clark
(University of Manchester
University of Manchester
Eberhard Karls University of Tübingen)
Abstract
Age-related macular degeneration (AMD) is a leading cause of blindness. Genetic variants at the chromosome 1q31.3 encompassing the complement factor H (CFH, FH) and CFH related genes (CFHR1-5) are major determinants of AMD susceptibility, but their molecular consequences remain unclear. Here we demonstrate that FHR-4 plays a prominent role in AMD pathogenesis. We show that systemic FHR-4 levels are elevated in AMD (P-value = 7.1 × 10−6), whereas no difference is seen for FH. Furthermore, FHR-4 accumulates in the choriocapillaris, Bruch’s membrane and drusen, and can compete with FH/FHL-1 for C3b binding, preventing FI-mediated C3b cleavage. Critically, the protective allele of the strongest AMD-associated CFH locus variant rs10922109 has the highest association with reduced FHR-4 levels (P-value = 2.2 × 10−56), independently of the AMD-protective CFHR1–3 deletion, and even in those individuals that carry the high-risk allele of rs1061170 (Y402H). Our findings identify FHR-4 as a key molecular player contributing to complement dysregulation in AMD.
Suggested Citation
Valentina Cipriani & Laura Lorés-Motta & Fan He & Dina Fathalla & Viranga Tilakaratna & Selina McHarg & Nadhim Bayatti & İlhan E. Acar & Carel B. Hoyng & Sascha Fauser & Anthony T. Moore & John R. W. , 2020.
"Increased circulating levels of Factor H-Related Protein 4 are strongly associated with age-related macular degeneration,"
Nature Communications, Nature, vol. 11(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-14499-3
DOI: 10.1038/s41467-020-14499-3
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- M. A. Zouache & B. T. Richards & C. M. Pappas & R. A. Anstadt & J. Liu & T. Corsetti & S. Matthews & N. A. Seager & S. Schmitz-Valckenberg & M. Fleckenstein & W. C. Hubbard & J. Thomas & J. L. Hageman, 2024.
"Levels of complement factor H-related 4 protein do not influence susceptibility to age-related macular degeneration or its course of progression,"
Nature Communications, Nature, vol. 15(1), pages 1-17, December.
- Valur Emilsson & Elias F. Gudmundsson & Thorarinn Jonmundsson & Brynjolfur G. Jonsson & Michael Twarog & Valborg Gudmundsdottir & Zhiguang Li & Nancy Finkel & Stephen Poor & Xin Liu & Robert Esterberg, 2022.
"A proteogenomic signature of age-related macular degeneration in blood,"
Nature Communications, Nature, vol. 13(1), pages 1-15, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-14499-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.